EUVIMEDSkopri EUVIMED
Open access · CC BY-NC-ND 4.0

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance

Ivair R Silva iD, Lily Wang, Judith C Maro

Statistics in Medicine · 2026-07 · 45 (15-17)

DOI: 10.1002/sim.70662 ↗

At a glance

Journal article in Statistics in Medicine, published online on 2026-07-02. Written by Ivair R Silva and 2 co-authors. Institution: Computer Department, Federal University of Ouro Preto, Ouro Preto, Minas Gerais, Brazil. Major MEDLINE topics: Vaccines, Product Surveillance, Postmarketing. 13 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: CDC HHS, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Amparo à Pesquisa do Estado de Minas Gerais.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

When multiple vaccines are simultaneously recommended, a statistical method to monitor adverse events accounting for multiple combinations of vaccine exposure rather than each vaccine individually is preferred. We introduce an adaptive multiple hypotheses test method for rapidly detecting increased risks of adverse events from one or more combinations of simultaneous vaccine exposure, for example, exposed to influenza vaccination only; exposed to COVID and influenza vaccinations; exposed to COVID, influenza, and respiratory syncytial virus (RSV) vaccinations. We do this by extending the binomial maximized sequential probability ratio test (MaxSPRT) method to a multinomial probability model. With an exact analytical alpha spending approach, the computationally feasible limit of multiple exposures is likely limited to two vaccines. For more complex situations with three or more vaccines and multiple adverse event endpoints, we demonstrate a valid Monte Carlo approach. Illustrative examples and simulation studies were performed with the R Sequential package.

Subjects

MeSH terms (MEDLINE)

VaccinesProduct Surveillance, PostmarketingHumansMonte Carlo MethodInfluenza VaccinesModels, StatisticalComputer SimulationCOVID-19 VaccinesVaccination

Author keywords

adverse eventexpected time to signalpostmarketing product surveillancepublic health surveillancerelative risksequential hypothesis testvaccine

Substances

Influenza VaccinesVaccinesCOVID-19 Vaccines

Authors and institutions

  • Computer Department, Federal University of Ouro Preto, Ouro Preto, Minas Gerais, Brazil.
  • Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
  • U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Harvard Medical School, Boston, Massachusetts, USA.

ORCID profiles: Ivair R Silva

Funding

  • CDC HHS
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação de Amparo à Pesquisa do Estado de Minas Gerais
  • Centers for Disease Control and Prevention

Cite

APA

Silva, I. R., Wang, L., & Maro, J. C. (2026). Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance. Statistics in Medicine, 45(15-17). https://doi.org/10.1002/sim.70662

Vancouver

Silva IR, Wang L, Maro JC. Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance. Statistics in Medicine. 2026;45(15-17). doi:10.1002/sim.70662

BibTeX
@article{Silva2026,
  author = {Silva, Ivair R and Wang, Lily and Maro, Judith C},
  title = {Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance},
  journal = {Statistics in Medicine},
  year = {2026},
  volume = {45},
  number = {15-17},
  doi = {10.1002/sim.70662}
}
Start for free →